Abstract
The 35kDa antigen of Mycobacterium leprae is a membrane component that contains both B and T-cell stimulating epitopes. Monoclonal antibodies, primarily specific to M. leprae, have been developed against this antigen. Moreover, this antigen has been genetically engineered. Using recombinant 35kDa antigen and/or a monoclonal antibody against an epitope on 35kDa, a variety of antibody/antigen detecting tests have been described for detection of M. leprae infection. 35kDa protein also stimulates peripheral blood mononuclear cells (PBMCs) from the majority of paucibacillary (PB) patients. Approaches using combined antibody and T cell are discussed.
| Original language | English (UK) |
|---|---|
| Pages (from-to) | 9-19 |
| Number of pages | 11 |
| Journal | Leprosy Review |
| Volume | 73 |
| Issue number | 1 |
| Publication status | Published - 2002 |
| Externally published | Yes |